在BTLA-HVEM复合体 - 癌症免疫治疗的未来
Karolina Wojciechowicz1, Marta Spodzieja2, Anna Wardowska1
1Department of Physiopathology, Faculty of Medicine, Medical University of Gdansk, Poland.
European journal of medicinal chemistry
|February 22, 2024
概括
针对B和T淋巴细胞减弱剂 (BTLA) -HVEM复合体对于癌症免疫治疗至关重要. 调节这种相互作用可以增强抗瘤免疫力,并为新型癌症和自身免疫性疾病的治疗提供潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- B和T淋巴细胞减弱剂 (BTLA) -HVEM复合体调节免疫反应,影响癌症进展和免疫治疗结果.
- 失调的BTLA和HVEM表达与各种癌症中的免疫抑制和瘤逃避有关.
- 异常的BTLA-HVEM信号破坏T细胞功能,导致瘤诱导的免疫抑制.
研究的目的:
- 在癌症的背景下,审查BTLA-HVEM复合物的结构,功能和相互作用.
- 讨论BTLA-HVEM失调在癌症预后和免疫治疗中的临床影响.
- 探索针对BTLA-HVEM轴的潜在治疗策略.
主要方法:
- 关于BTLA-HVEM结构,功能和相互作用的研究文献综述.
- 对癌症中可溶性和跨膜BTLA-HVEM表达的数据的分析.
- 针对BTLA-HVEM相互作用的抑制剂的审查.
主要成果:
- 在瘤微环境中,BTLA-HVEM轴在免疫调节中起着重要作用.
- 改变的BTLA-HVEM表达与不同癌症类型的患者预后相关.
- 阻断BTLA-HVEM相互作用的抑制剂显示出治疗潜力.
结论:
- 准BTLA-HVEM复合体为增强抗瘤免疫力和开发新型癌症免疫疗法提供了一个有前途的战略.
- 调节BTLA-HVEM相互作用也可能有利于控制自身免疫性疾病.
- 需要进一步的研究,以充分阐明BTLA-HVEM轴生物学,并确认其临床应用.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910


